MHRA approves Sharp’s clinical services center in Wales

By Maggie Lynch contact

- Last updated on GMT

(Image: Getty/eivaisla)
(Image: Getty/eivaisla)

Related tags: Sharp clinical packaging, Mhra, Clinical development, Wales, facility, Service

Sharp’s clinical services center is approved by the MHRA and now ready to offer services for serialization and trial management while reducing carbon footprint with the addition of solar panel systems.

After an inspection by the Medicines and Healthcare Product Regulatory Agency (MHRA), Sharp will now offer clinical trial and commercial services at its $12.67m (£9.7m) Clinical Services Center of Excellence​ in Rhymney, Wales.

The center will enable Sharp to offer integrated services such as serialization and interactive response technology (IRT) solutions for clinical trial management. The new facility also triples its clinical service capacity.

IRT solutions offered at the center are made available after Sharp recently invested $650,000 in the technology​ in an aim to ensure proper supply allocations for its clinical trials. At the time, Sharp stated that the addition of IRT mitigates the potential cost of overproduction in clinical trials.

Frank Lis, president of Sharp Clinical Services, said in a statement that the facility will be able to provide full-service support to meet the growing global demand for Phase III clinical trials and commercial services.

Sharp has additionally invested in a solar panel system to generate approximately 20% of its total annual electricity requirements at the site. This system will reduce the company’s carbon footprint and improve environmental performance.

Not long before the completion and approval of the Welsh site, Sharp completed an expansion of its clinical facility in Bethlehem, PA​ in the US to refit the facility and relocate services from the company’s previous Phoenixville site.

The clinical services company received the MHRA approval just as it celebrated its 30th ​year in clinical operations in the UK.

Related news

Show more

Related products

show more

Laboratory Solutions for COVID-19 Clinical Trials

Laboratory Solutions for COVID-19 Clinical Trials

Q2 Solutions | 10-Jun-2020 | Clinical Study

As a leading laboratory services organization for trials across the globe, we are proud to partner with clients to support COVID-19 clinical trials. Our...

Parents as Gatekeepers for Children with Cancer

Parents as Gatekeepers for Children with Cancer

PRA Health Sciences | 08-Jun-2020 | Technical / White Paper

The RACE for Children Act will require new drugs intended for adult cancer treatment to also be studied in pediatric cancers when the molecular target...

Related suppliers

Follow us


View more